24-Hour ambulatory blood pressure monitoring

American Heart Journal

Volumn 151, Issue 5, 2006, Pages 962-968

  O'Shea, J Conor ^a,b   Califf, Robert M ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; BRAIN DAMAGE; CARDIOVASCULAR RISK; CHRONOBIOLOGY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DRUG SCREENING; HUMAN; HYPERTENSION; MEDICAL CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; DRUG EVALUATION; HUMANS; HYPERTENSION; REFERENCE VALUES; RISK ASSESSMENT;

EID: 33646120084     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.020     Document Type: Article

References (63)

1. Schappert SM. National ambulatory medical survey: 1991 summary. NCHS Advance Data, No. 230, Vital and Health Statistics of the National Center for Health Statistics. US Department of Health and Human Services Publication (PHS) 93-1250. Hyattsville, MD, March 29, 1993.
2. O'Brien E., Atkins N., and Staessen J. State of the market. A review of ambulatory blood pressure monitoring devices. Hypertension 25 (1995) 835-842
3. Pickering T.G., and for an American Society of Hypertension Ad Hoc Panel. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 9 (1996) 1-11
4. American College of Physicians. Automated ambulatory blood pressure monitoring devices: their role in the diagnosis and management of hypertension. Ann Intern Med 118 (1993) 889-892
5. Mancia G. Clinical use of ambulatory blood pressure monitoring. Am J Hypertens 2 (1989) 50S-54S
6. National High Blood Pressure Education Program Coordinating Committee. National High Blood Pressure Education Program Working Group report on ambulatory blood pressure monitoring. Arch Intern Med 150 (1990) 2270-2280
7. Sheps S.G., Clement D.L., and Pickering T.G. ACC position statement. Ambulatory blood pressure monitoring. J Am Coll Cardiol 23 (1994) 1511-1513
8. Staessen J.A., Beilin L., and Parati G. Task force IV: clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring. Blood Press Monit 4 (1999) 319-331
9. O'Brien E., Coats A., and Owens P. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 320 (2000) 1128-1134
10. O'Brien E. Proceedings from a workshop on measurement of blood pressure of the working group on blood pressure monitoring of the European Society of Hypertension, Milan, June 1999. Blood Press Monit 5 (2000) 31-32
11. O'Brien E., Beevers G., and Lip G.Y. ABC of hypertension. Blood pressure measurement. Part III-automated sphygmomanometry: ambulatory blood pressure measurement. BMJ 322 (2001) 1110-1114
12. Mancia G., Sega R., and Bravi C. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 13 (1995) 1377-1390
13. Mancia G., Omboni S., and Ravogli A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Press 4 (1995) 148-156
14. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 35 (2000) 844-851
15. Mancia G., and Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 36 (2000) 894-900
16. Fagard R., Staessen J.A., and Thijs L. The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 13 (1995) 823-829
17. Fagard R., Staessen J., and Thijs L. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring. A metaanalysis of comparative studies. Am J Hypertens 8 (1995) 533-540
18. Palatini P., Morimino P., and Martina S. Blood pressure variability and night-time blood pressure versus hypertensive cardiovascular complications: an analysis on 522 subjects. Cardiologia 35 (1990) 217-222
19. Redon J., Liao Y., and Lozano J.V. Ambulatory blood pressure and microalbuminuria in essential hypertension: role of circadian variability. J Hypertens 12 (1994) 947-953
20. Shimada K., Kawamoto A., and Matsubayashi K. Silent cerebrovascular disease in the elderly: correlation with ambulatory blood pressure. Hypertension 16 (1990) 692-699
21. Fagard R.H., Staessen J.A., and Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 29 (1997) 22-29
22. Perloff D., Sokolow M., and Cowan R. The prognostic value of ambulatory blood pressure. JAMA 249 (1983) 2793-2798
23. Perloff D., Sokolow M., and Cowan R.M. Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 7 (1989) S3-S10
24. Verdecchia P., Porcellati C., and Schillaci G. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 24 (1994) 793-801
25. Mancia G., Zanchetti A., and Agabiti-Rosei E. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation 95 (1997) 1464-1470
26. Staessen J.A., Thijs L., and Fagard R. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 282 (1999) 539-546
27. Staessen J.A., Fagard R., and Thijs L. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350 (1997) 757-764
28. Kario K., Matsuo T., and Kobayashi H. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive subjects: advanced silent cerebrovascular damage in extreme dippers. Hypertension 27 (1996) 130-135
29. O'Brien E., Sheridan J., and O'Malley K. Dippers and non-dippers. Lancet 2 (1988) 397
30. Verdecchia P., Schillaci G., and Guerrieri M. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81 (1990) 528-536
31. Rizzoni D., Muiesan M.L., and Montani G. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens 5 (1992) 180-186
32. Kuwajima I., Suzuki Y., and Shimosawa T. Diminished nocturnal decline in blood pressure in elderly hypertensive patients with left ventricular hypertrophy. Am Heart J 67 (1992) 1307-1311
33. Palatini P., Penzo M., and Racioppa A. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. Arch Intern Med 152 (1992) 1855-1860
34. Schmieder R.E., Rockstroh J.K., and Äpfelbacher F. Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am J Hypertens 8 (1995) 1160-1166
35. Shimada K., Kawamoto A., and Matsubayashi K. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 10 (1992) 875-878
36. Bianchi S., Bigazzi R., and Baldari G. Diurnal variations of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 7 (1994) 23-29
37. Fagard R.H., Staessen J.A., and Thijs L. The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 13 (1995) 823-829
38. Joint National Committee. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157 (1997) 2413-2446
39. Pickering T.G., Coats A., and Mallion J.M. Blood pressure monitoring. Task force V: white-coat hypertension. Blood Press Monit 4 (1999) 333-341
40. Verdecchia P., Schillaci G., and Borgioni C. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 8 (1995) 790-798
41. Pickering T.G., James G.D., and Boddie C. How common is white coat hypertension?. JAMA 259 (1988) 225-228
42. Staessen J.A., O'Brien E.T., and Amery A.K. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens 12 (1994) S1-S12
43. Cavallini M.C., Roman M.J., and Pickering T.G. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?. Hypertension 26 (1995) 413-419
44. Cuspidi C., Marabini M., and Lonati L. Cardiac and carotid structure in patients with established hypertension and white coat hypertension. J Hypertens 13 (1995) 1707-1711
45. Khattar R.S., Senior R., and Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: a 10-year follow-up study. Circulation 98 (1998) 1892-1897
46. Palatini P., Mormino P., and Santonastaso M. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 31 (1998) 57-63
47. Hoegholm A., Bang L.E., and Kristensen K.S. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension 24 (1994) 101-105
48. Redon J., Campos C., and Narciso M.L. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 31 (1998) 712-718
49. Fagard R.H., Staessen J.A., and Thijs L. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation 102 (2000) 1139-1144
50. Pickering T.G., Levenstein M., and Walmsley P. Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension. Results of the HALT Study. Hypertension And Lipid Trial Study Group. Am J Hypertens 7 (1994) 848-852
51. Weber M.A., Cheung D.G., and Graettinger W.F. Characterization of antihypertensive therapy by whole-day blood pressure monitoring. JAMA 259 (1988) 3281-3285
52. Palatini P., Dorigatti F., and Roman E. White-coat hypertension: a selection bias? Harvest Study Investigators. Hypertension and Ambulatory Recording VEnetia STudy. J Hypertens 16 (1998) 977-984
53. Rose G. Epidemiology. In: Marshall A.J., and Barritt D.W. (Eds). The Hypertensive Patient (1980), Pitman Medical, Kent (England) 1-21
54. O'Brien E., and Staessen J.A. What is "hypertension"?. Lancet 353 (1999) 1541-1543
55. Staessen J.A., Byttebier G., and Buntinx F. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA 278 (1997) 1065-1072
56. Coats A.J., Radaelli A., and Clark S.J. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertens 10 (1992) 385-391
57. Conway J., Johnston J., and Coats A. The use of ambulatory blood pressure monitoring to improve the accuracy and reduce the numbers of subjects in clinical trials of antihypertensive agents. J Hypertens 6 (1988) 111-116
58. Mancia G., Omboni S., and Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens 15 (1997) S43-S50
59. Gould B.A., Mann S., and Davies A.B. Does placebo lower blood-pressure?. Lancet 2 (1981) 1377-1381
60. Mutti E., Trazzi S., and Omboni S. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 9 (1991) 361-364
61. Mancia G., Omboni S., and Parati G. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 8 (1995) 311-315
62. Staessen J.A., Thijs L., and Mancia G. Clinical trials with ambulatory blood pressure monitoring: fewer patients needed? Syst-Eur Investigators. Lancet 344 (1994) 1552-1556
63. Fenichel R.R., and Lipicky R.J. On the trough-to-peak ratio of drug effect in antihypertensive trials. Am J Hypertens 9 (1996) 105S-107S